SCHEMBL17599321

SCHEMBL17599321

CCCCCCCCc1cc(-c2cccc(C(=O)OC(C)(C)C)c2)c2ccccc2c1NS(=O)(=O)c1c(C)c(C)cc(C)c1C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCL1 Q07820 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ CRHBP P24387 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ CRHR2 Q13324 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ SQSTM1 Q13501 2/20 0.34
▸ KEAP1 Q14145 2/20 0.34
▸ NFE2L2 Q16236 2/20 0.34
▸ TRPV1 Q8NER1 1/20 0.33
▸ ROCK2 O75116 2/20 0.33
▸ ABCB1 P08183 1/20 0.33
▸ ABCG2 Q9UNQ0 1/20 0.33
▸ PTPN11 Q06124 1/20 0.33
▸ SLC7A5 Q01650 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ HSD17B1 P14061 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599393 0.88 MCL1 (0.42) MCL1KDM4EMEN1ALDH1A1HPGD
SCHEMBL17599386 0.85 MEN1 (0.37) MCL1KDM4EMEN1ALDH1A1HPGD
SCHEMBL17599308 0.85 FAAH (0.34) MCL1KDM4EMEN1ALDH1A1HPGD
SCHEMBL17599409 0.83 MEN1 (0.38) KDM4EMEN1ALDH1A1HPGDCRHBP
SCHEMBL17599380 0.79 MEN1 (0.44) MCL1KDM4EMEN1ALDH1A1HPGD
SCHEMBL17599366 0.72 KDM4E (0.41) KDM4EMEN1ALDH1A1HPGDCRHBP
SCHEMBL17599346 0.71 CDC25B (0.45) KDM4EMEN1ALDH1A1HPGDCRHBP
SCHEMBL17613335 0.65 ABCG2 (0.37) ABCB1ABCG2SLC7A5SMN1; SMN2CNR2
SCHEMBL17599410 0.64 ABCG2 (0.35) ABCB1ABCG2SLC7A5
SCHEMBL10041932 0.63 SREBF2 (0.43) CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
Send feedback